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Abstract
Background: Induced pluripotent stem (iPS) cells are generated from mouse and human somatic cells by the forced
expression of defined transcription factors. Although most somatic cells are capable of acquiring pluripotency with minimal
gene transduction, the poor efficiency of cell reprogramming and the uneven quality of iPS cells are still important
problems. In particular, the choice of cell type most suitable for inducing high-quality iPS cells remains unclear.
Methodology/Principal Findings: Here, we generated iPS cells from PDGFRa
+ Sca-1
+ (PaS) adult mouse mesenchymal stem
cells (MSCs) and PDGFRa
2 Sca-1
2 osteo-progenitors (OP cells), and compared the induction efficiency and quality of
individual iPS clones. MSCs had a higher reprogramming efficiency compared with OP cells and Tail Tip Fibroblasts (TTFs).
The iPS cells induced from MSCs by Oct3/4, Sox2, and Klf4 appeared to be the closest equivalent to ES cells by DNA
microarray gene profile and germline-transmission efficiency.
Conclusions/Significance: Our findings suggest that a purified source of undifferentiated cells from adult tissue can
produce high-quality iPS cells. In this context, prospectively enriched MSCs are a promising candidate for the efficient
generation of high-quality iPS cells.
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Introduction
Pioneering work by Takahashi et al showed that the ectopic
expression of a defined set of transcription factors, Oct4, Klf4,
Sox2, and c-Myc, reprograms mouse embryonic fibroblasts
(MEFs) and adult tail-tip fibroblasts (TTFs) into embryonic stem
(ES)-like cells called induced pluripotent stem (iPS) cells [1]. Since
then, iPS cells have been generated from a variety of somatic cells,
including embryonic and adult dermal fibroblasts [1,2,3],
epithelial cells of the liver and stomach [4], pancreatic b cells
[5], mature B lymphocytes [6], and adult neural stem cells (NSCs)
[7,8]. These studies demonstrated that most somatic cells can be
reprogrammed with 4 or 3 factors (excluding c-Myc).
However, each cell source may have a unique requirement
for the specific factors that induce reprogramming. For
example, embryonic fibroblasts are more easily reprogrammed
than adult ones [1,9]. Mature B cells require an additional
factor to trigger epigenetic change, whereas NSCs require only
1 or 2 factors to become iPS cells. These data raise two
possibilities: 1) embryonic tissue is a better source for iPS cells
than adult tissue, and 2) tissue stem cells are more suitable for
reprogramming than differentiated cells. However, it is difficult
to compare the reprogramming efficiency among mixed cell
populations such as MEFs or TTFs. Furthermore, nothing
conclusive can be learned from comparing cells of different
l i n e a g e s ,s u c ha sBl y m p h o c y t e sv e r s u sN S C s .S o m a t i cc e l l s
constitute a developmental hierarchy of stem cells, progenitor
cells, and mature cells. To test our hypothesis that stem cells are
more efficiently reprogrammed into iPS cells than mature ones,
we needed to compare cells from the same cell lineage but from
distinct developmental stages.
Here we focused on highly enriched mesenchymal stem cells
(MSCs) and osteo-progenitors. Both cell types belong to the
mesenchymal lineage and maintain unique undifferentiated
states. We previously established a method for isolating highly
enriched MSCs and osteo-progenitors from adult murine bone
marrow based on their expression of PDGFRa and Sca-1. Cells
expressing both PDGFRa and Sca-1 (PaS) are MSCs that are
120,000-fold more enriched for clonogenic cells (CFU-Fs
[10,11,12]) than unfractionated bone marrow [13,14]. On the
other hand, cells in the PDGFRa-negative, Sca-1-negative
represents osteo-progenitors (OP) that can differentiate only into
osteocytes (Figure 1A). We isolated each population to compare
the efficiency of reprogramming.
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Generation of iPS cells with distinct subsets of
mesenchymal lineage
Each isolated cell type (PaS, OP, Tail Tip Fibroblast (TTF),
and Mouse Embryonic Fibroblast (MEF)) was retrovirally
transduced with 4 or 3 factors [15] along with CAG-DsRed
[16] as a control for the induction efficiency, which was similar
for both cell populations (Figure S1). From 1610
4 DsRed-
positive cells induced with 4 factors, we obtained over 200 iPS
colonies from the PaS and OP cells, which was approximately
the same amount obtained with control TTFs and MEFs
counted 35 days after retroviral transduction (Figure 1B).
Nanog is specifically expressed in ES cells and pre-implantation
embryos [17,18] and is an indicator for pluripotency during
iPS-cell induction [19]. The Nanog GFP
+/DsRed
2 colonies
were morphologically indistinguishable from mouse ES cells
(Figure 1C), but the GFP
+/DsRed
+ colonies showed slightly
flat with unclear margins (Figure 1D). From what we found in
the comparison of GFP
+/DsRed
2 colonies was that the PaS
Figure 1. Generation of iPS cells from three cell sources obtained from Nanog-GFP-Puro
r transgenic mice. A, FACS profile and
differentiation capacity of PaS cells and OP cells. PaS cells positive for PDGFRa and Sca-1 after gating on CD45
2 and Ter119
2. OP cells negative for
PDGFRa and Sca-1 after gating on CD45
2 and Ter119
2. Phase-contrast is a micrograph of CFU-Fs from PaS cells. Osteogenesis was indicated by
alkaline phosphatase staining on day 14, adipogenesis by neutral lipid vacuoles stained with oil red O on day 14, and chondrogenesis by toluidine
blue staining on day 21 and by morphological changes of PaS (top) and OP (bottom) cells. B, Number of total colonies (counted EGFP
+ and EGFP
2
cells) obtained from 4Factor-transfection of PaS cells, OP cells, TTFs, and MEFs. Colonies were counted 28 days after retroviral transduction and 1610
4
cells were replated. C, Phase and fluorescence images of PaS iPS GFP
+/DsRed
2 colony. D, Phase and fluorescence images of PaS iPS GFP
+/DsRed
+
colony. E, Number of GFP
+/DsRed
2 colonies from 4-factor induction. *P,0.05 (n=3). F, Number of total colonies (counted EGFP
+ and EGFP
2 cells)
from 3-factor induction. Colonies were counted 35 days after retroviral transduction and 1610
4 cells were replated. *P,0.05 (n=3). G, Number of
GFP
+/DsRed
2 colonies from 3-factor induction. **P,0.01 (n=3). Bar, 200 mm.
doi:10.1371/journal.pone.0017610.g001
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PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17610Figure 2. Gene expression and in vivo differentiation of iPS cells. RT-PCR of 4F-iPS cells (A) and 3F-iPS cells (B) for ES-cell marker genes,
including Eras, Rex1, Dax1, Gdf3, Esg1, Nanog, Oct3/4, and Sox2 and to detect silencing of the transgenes. C, Number of ES-cell marker genes
expressed using 4F induction. D, Number of ES-cell marker genes expressed using 3F induction. E, Transgenes silenced in 4F induction. F, Transgenes
silenced in 3F induction. G, Teratomas from iPS cells, transplanted subcutaneously into nude mice. After 4-6 weeks, the teratomas were analyzed
histologically with haematoxylin and eosin staining. TTF-iPS 4F1 did not differentiate mesoderm. H, Undifferentiated cells from 4F OP-iPS #3.
doi:10.1371/journal.pone.0017610.g002
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GFP
+/DsRed
2 and puromycin-resistant colonies than the OP-,
TTF-, and MEF-derived iPS cells counted 7 days after adding
puromycin (Figure 1E). When the cells were induced with 3
factors (without c-Myc), the PaS cells yielded not only more ES-
like colonies counted 42 days after retroviral transduction, but
Figure 3. Characterization of iPS cells and PaS cells. A, DNA methylation of the promoter region of the Nanog gene. White circles indicate
unmethylated CpG dinucleotides; black circles indicate methylated CpG dinucleotides. B, Scatter plots showing the comparison of global gene
expression between ES cells and PaS-iPS, OP-iPS, and TTF-iPS cells determined by DNA microarray. Red number; R
2 values over 0.92 compared with ES
cells as positive. C, Microarray Scatter Plots were especially showing klf4, Sox2, Pou5f1 (Oct3/4), Nanog, c-Myc, Tbx3, and GM397 (Zscan4) gene.
doi:10.1371/journal.pone.0017610.g003
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+/DsRed
2 colonies, compared to the OP cells,
T T F s ,o rM E F su s i n g3o r4f a c t o r s ,c o u n t e d7d a y sa f t e rt h e
addition of puromycin (Figure 1F and G). We also confirmed
the higher induction efficiency of PaS cells compare to TTFs by
using integration-free method (Table S1), and immune-
deficient NOD/Shi-scid and IL-2Rc
null (NOG)m i c et h a ti sa
well known non-permissive strain (Matsui et al. manuscript in
preparation).
Characterization of iPS clones derived from PaS, OP or
TTF
Next, we randomly selected five GFP
+/DsRed
2 clones from
each adult cell source (PaS, OP, and TTF) and verified the quality
of individual clones. We first analyzed the marker-gene expression
for undifferentiated ES cells and transgene silencing by RT-PCR.
All 4-factor (4F-) and 3-factor (3F-) induced P(S-iPS clones
uniformly expressed all the ES-cell marker genes (Figure 2A–D),
but completely lost all transgene expression (Figure 2E and F). In
addition, although we chose DsRed
2 clones, the transgene
silencing was incomplete in several OP-iPS and TTF-iPS clones
(Figure 2E and F). The PaS-iPS clones were also homogenously
positive for the immature ES-cell markers alkaline phosphatase
(ALP) and SSEA-1, but some of the OP-/TTF-iPS clones showed
a heterogeneous phenotype for SSEA-1 expression (Figure S2A
and B).
We next examined the pluripotency of each iPS clone by
teratoma formation. All of the 4F-/3F-induced PaS-iPS clones
formed teratomas, although 4F-OP-iPS #3 and 4F-TTF-iPS #1
clones did not differentiate into all three germ layers or remained
undifferentiated cells. (Figure 2G and H, Figure S3).
Interestingly, some of the OP-/TTF-iPS clones that lacked several
ES-cell marker genes still differentiated into all three germ layers
as teratomas (Figure 2A–F).
Bisulfate genomic sequencing of the Nanog promoter
revealed that the primary PaS and OP cells were similarly
methylated as TTFs [20] and hepatocytes [4] (Figure 3A).
DNA microarray analysis confirmed that all of the PaS-iPS
clones had similar ES-cell-like gene expression profiles detected
by R
2 value (Figure 3B). From Microarray analysis, two of the
OP and one of the TTF clones that expressed relatively low
levels of Sox2, Nanog, and Zscan4 [21] also showed heavy
methylation of the Nanog promoter legion. Also, two of these
clones (4F-OP-iPS #3 and 4F-TTF-iPS # 1) did not show
pluripotency in the teratoma assay. Therefore, the global gene
expression profile and Nanog promoter methylation patterns
correlated with the functional quality of these clones. However,
two of the heavily methylated TTF-derived clones had ES-cell-
like gene expression profiles, including Nanog (Figure 3A and
C) and formed three-germ-layer teratomas (Figure S3).
Collectively, our data showed that iPS clones generated from
PaS cells had uniform profiles in all the assays, whereas the
OP-/TTF-derived iPS clones showed divergence, even among
those that were isolated by Nanog-puromycin resistance
GFP
+DsRed
2 selection (Table S2).
Chimeras from PaS-iPS cells
We next investigated whether the PaS-iPS cells were of a
sufficient quality to produce adult chimeras. From previous
examinations, OP-iPS clones and TTF iPS clones could not pass
the total quality assessment, excluding 3F-OP-iPS #4( Table S1).
We selected three 4F-PaS-iPS, three 3F-PaS-iPS, and one from
each 3F-OP-iPS and 4F-TTF-iPS (Table S2). These cells were
introduced into eight-cell-stage ICR embryos by aggregation [22].
The P(S-iPS cells were well integrated into the inner cell mass
during the maturation process, whereas a large number of OP-iPS
and TTF-iPS cells were not (Figure S4). Two of the three 4F-
PaS-iPS and all of the 3F-PaS-iPS contributed to chimeras. Most
of the PaS-iPS clones competently generated adult chimeric mice,
whereas none of the OP-/TTF-iPS-aggregated embryos resulted
in chimeric mice.
Interestingly, the 3F-PaS-iPS clones clearly showed higher
chimerism efficiency than the 4F-clones (Figure 4A). This
suggested that the 3F-PaS-iPS cells were more efficient in
colonizing germ tissues. Therefore, using one of the most stringent
criteria for demonstrating the quality of iPS clones [23], we next
tested the frequency of their germ-line transmission and the
production of viable F1 offspring.
Five of the nine chimeric animals were infertile, which could be
explained by hermaphroditism of the chimeric mice [24], since
both of the iPS clones were of male origin. The other four
chimeras produced litters of which two had 100% black offspring,
and two had between 16% and 29% black offspring (Figure 4B).
Nanog-GFP-IRES-Puro
r transgene integration was identified by
genomic DNA PCR in 60% of the black offspring. Since the
original PaS cells were derived from heterozygous Tg animals,
approximately half of the F1 offspring were expected to possess the
integrated transgene (Figure 4C). In the germ-line competent 3F-
PaS-iPS cells, the expression levels of Gtl2 and Rian, which are
associated with germ-line contribution, were similar to those of ES
cells, but their levels were slightly lower in #4( Figure 4D).
The DNA microarray hierarchical clustering data confirmed
that the 3F-PaS-iPS clones were the closest to ES cells among the
clones derived from the various cell sources, and even the 4F-PaS-
iPS cells (Figure 4E).
Discussion
Here we demonstrated that highly enriched mesenchymal stem
cells (PaS cells) produce high-quality iPS clones at a high
frequency. All the PaS-derived clones we tested had immature
ES-cell-like characteristics, according to their gene expression, in
vivo pluripotency, and the competency to produce adult chimeric
mice. In addition, we have not observed the early death of
chimeric mice, as was previously reported [4], in either the 3F- or
4F-PaS-iPS-containing chimeras, which have lived more than 52
weeks, to date. This is another advantage of using purified MSCs
as the iPS cell source. Selection markers driven by the Nanog/
Oct4 promoter allowed us to obtain high quality iPS cells at a
higher frequency than Fbx15 promoter selection [1,19]. However,
it is well known that most Nanog/Oct4-GFP-positive clones are
Figure 4. Germline chimeras and offspring from PaS-iPS cells. A, Chimeric and F1 mice from 4F-PaS-iPS and 3F-PaS-iPS cells. 3F-PaS-iPS could
observe nine over 50% chimerism chimeras. B, Germline-competent chimeric mice and F1 mice. Seven chimeras (.50% coloured coat colour) from
3F-PaS-iPS #1 and two from 3F-PaS-iPS #2 were bred with ICR females, and three of seven chimeas from 3F-PaS-iPS #1 and one of two chimera
from 3F-PaS-iPS #2 produced iPS derived F1 mice. The ratio of pigmented F1 mice was observed. Numbers below each panel give the percentage of
pigmented F1 mice. C, PCR analysis showing the presence of the GFP cassette in F1 mice obtained from the intercross between a chimeric male and
an ICR female. D, Scatter plots compared the Gtl2 and Rian gene expression between 4F/3F PaS-iPS and ES cells. E, Hierarchical clustering comparing
the global gene expression between ES and iPS cells determined by DNA microarray. F, Scatter plots comparing the global gene expression between
ES cells and source cells including PaS cells, OP cells, and TTF cells determined by DNA microarray.
doi:10.1371/journal.pone.0017610.g004
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‘‘junk’’ cells [25]. Therefore, a series of screening processes is
required to ensure the iPS cells are ‘‘qualified.’’ Using purified
MSCs as a cell source may relieve the researcher of this tedious
process.
Our results also revealed that 3F induction (without c-Myc) was
more efficient for the germ-line transmission of PaS-iPS. This was
an interesting observation, since it is known that 3F-induced MEFs
or TTFs rarely produce germ-line transmissible iPS clones [25,26].
As already reported, mouse and human NSCs can be repro-
grammed with Oct4 and Klf4 only, since NSCs intrinsically
express Sox2 and c-Myc [7,8]. Our DNA microarray analysis
revealed that the original PaS cells expressed c-Myc, Klf4, and
Tbx3 [26] mRNA at similar levels as ES cells, but their levels in
the OP cells and TTFs were lower (Figure 4F). This was also
consistent with our observation that c-Myc transduction was not
required for the complete reprogramming of PaS cells. A recent
publication demonstrated that germ-line-competent iPS cells are
easily obtained when c-Myc is replaced by Tbx3 [26]. That PaS
cells and ES cells express equivalent levels of both c-Myc and
Tbx3 may be another reason for the enhanced reprogramming
and germ-line transmission of the PaS cells. However, unlike with
NSCs, we could not obtain iPS cells from PaS cells when Klf4 or
c-Myc and Klf4 were not among the transduced factors. These
results suggest that exogenous c-Myc is dispensable, but Klf4 is
required for deriving iPS cells from PaS cells.
We conclude that immature tissue stem cells (PaS cells) are a
more efficient source of iPS cells than partially committed ones
(OP cells) or a mixed cell population (TTFs) of the same lineage.
Among the various tissue stem cells that can be isolated from
adults, MSCs in the bone marrow are the most easily accessible,
and can be obtained less invasively than NSCs or stomach
cells[4,7,8,9]. If human MSCs show the same features as murine
MSCs, the clinical implications of this finding will be immense, not
only because human MSCs would be an ideal source of high-
quality iPS cells, but also because existing bone-marrow banks
could be exploited to prepare HLA-specific iPS cells for use in
regenerative medicine.
Materials and Methods
Preparation of bone-marrow cell suspension
The mice were kept under specific pathogen-free conditions in
our animal facility at keio University School of Medicine. All
experimental procedures and protocols were approved by the
ethics committee of Keio University and were in accordance with
the Guide for the Care and Use of Laboratory Animals. Approval
ID: 09089-(8). Mouse femurs and tibias were dissected out and
crushed with a pestle. The crushed bones were washed in HBSS
+
(Gibco) supplemented with 2% FBS, 10 mM HEPES, and 1%
Penicillin/Streptomycin(P/S) to remove the hematopoietic cells.
The bone fragments were incubated for 1 hr at 37uC in 0.2%
collagenase (Wako) in DMEM (Gibco) containing 10 mM HEPES
and 1% P/S. The suspension was filtered through a cell strainer
(Falcon) and collected by centrifugation at 2806g for 7 min at
4uC. The pellet was resuspended for 5–10 s in 1 ml water to burst
red blood cells, after which 1 ml of 2 6PBS containing 4% FBS
was added. The cells were resuspended in HBSS
+ and poured
through a cell strainer.
Flow cytometry analysis and cell sorting
The following fluorescently conjugated antibodies (PE, APC, or
FITC) were used for analysis and cell sorting: PE-conjugated
CD45 (30-F11), TER119 (TER-119), and SSEA-1, APC-conju-
gated PDGFRa (APA5), and FITC-conjugated Sca-1 (Ly6A/E).
Flow-cytometry analysis and sorting were performed on a triple-
laser MoFlo (Dako) or JSAN (Bay Bioscience) flow cytometer. PI
fluorescence was measured, and a live cell gate was defined that
excluded the cells positive for PI. Additional gates were defined as
positive for PDGFRa and Sca-1 and negative for CD45 and
TER119, according to the isotype control fluorescence intensity.
Live iPS cells gated in the PI-negative region were stained for
SSEA-1 for analysis.
Cell culture
Mouse MSCs were maintained in MEM-a containing 10%FBS,
1% P/S, and 10 mM HEPES. The iPS cells were maintained in
ES medium (DMEM containing 15% FBS, 1 6 NEAA, 1 mM
sodium pyruvate, 5.5 mM 2-ME, 50 units ml
21 penicillin, and
50 mgml
21 streptomycin) on feeder layers of mitomycin-C-treated
SNL cells into which we had stably incorporated the puromycin-
resistance gene. As a source of LIF, we used conditioned medium
from Plat-E cell cultures that had been transduced with a LIF-
expressing vector. Plat-E cells, which were also used to produce
retroviruses, were maintained in DMEM containing 10% FBS, 50
unitsml
21 penicillin, 50 mgml
-1 streptomycin, 1 mgml
21 puromy-
cin, and 10 mgml
21 blasticidin S. To establish TTFs, the tails from
adult mice were peeled, minced into 1-cm pieces, placed on
culture dishes, and incubated in MF-start medium (Toyobo) for 5
days. Cells that migrated out of the tail pieces were transferred to
new plates (Passage 2) and maintained in DMEM containing 10%
FBS. TTFs at Passage 3 were used to make iPS cells. ES and iPS
cells were cultured as previously described[1].
Generation of induced pluripotent stem cells
The iPS induction was performed as described previous-
ly[1,15] with some modifications. Briefly, PaS cells, OP cells,
T T F s ,a n dM E F sw e r ei s o l a t e df r o m6 - w e e k - o l dN a n o g - r e p o r t e r
mice. Plat-E cells were seeded at 8610
6 cells per 100-mm dish.
On the next day, 9 mg of pMX-based retroviral vectors for
DsRed, Oct3/4, Sox2, Klf4, and c-Myc were individually
introduced into separate dishes of Plat-E cells using 27 mlo f
FuGENE 6 transfection reagent. After 24 h, the medium was
replaced with 10 ml of DMEM containing 10% FCS. The
source cells were seeded at 1610
4 cells per 60-mm dish covered
with feeder cells. On the next day, virus-containing supernatants
from the Plat-E cultures were recovered and filtered through a
0.45-mm cellulose acetate filter. Equal volumes of the superna-
tants were mixed and supplemented with polybrene at a final
concentration of 4 mgml
21. We prepared the PaS cells, OP cells,
and TTFs concurrently. Two weeks after the cell expansion
following cell sorting, we transduced the three types of source
cells with 4 or 3 factors (without c-Myc) and DsRed as a marker
for infection efficiency and transg e n es i l e n c i n g .T h es o u r c ec e l l s
were incubated in the virus/polybrene-containing supernatants
for 24 h. Two days after infection, the medium was changed to
ES medium supplemented with LIF. Three days after infection,
1610
4 DsRed
+-infected cells were plated on feeder cells. Three
weeks after infection, the 4F cells were selected by puromycin
(Sigma); four weeks after infection, the 3F cells were selected.
One week after puromycin selection, the total colony number
was counted. For Nanog iPS cells, puromycin (Sigma) was
added at a final concentration of 1.5 mgml
21.
RT-PCR
Total RNA was purified with Trizol (Invitrogen) and treated
with a Turbo DNA-free kit (Ambion) to remove genomic DNA
contamination. The total RNA was used for a transcription
Germ-Line Competent iPS Cells from Purified MSC
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manufacturer’s instructions. PCR was performed with ExTaq
(Takara, Japan).
Teratoma formation and histological analysis
ES cells or iPS cells were suspended at 1610
7 cells/ml in
DMEM containing 10% FBS. Nude mice were anesthetized with
diethyl ether. Then, 100 ml of the cell suspension (1610
6 cells) was
injected subcutaneously into the dorsal flank. Four weeks after the
injection, the tumours were surgically dissected from the mice,
weighed, fixed in PBS containing 4% formaldehyde, embedded in
paraffin, and sectioned. The sections were stained with haema-
toxylin and eosin. Injection was done three times for all clones.
Bisulfite genomic sequencing
Bisulfite treatment was performed using the CpGenome
modification kit (Chemicon) according to the manufacturer’s
recommendations. The treated DNA was purified with a QIAquick
column(Qiagen).Theamplifiedproductswerecloned intopCR2.1-
TOPO (Invitrogen). Ten randomly selected clones were sequenced
with the M13 forward and M13 reverse primers for each gene.
DNA microarray
The total RNA from ES cells, PaSc e l l s ,O Pc e l l s ,T T F s ,a n di P S
cells was labelled with Cy3. Samples were hybridized to a Mouse
Oligo Microarray (Agilent) according to the manufacturer’s protocol.
The arrays were scanned with a G2565BA Microarray Scanner
System (Agilent). Data were analysed using GeneSpring GX software
(Agilent). Genes for which the value fluctuated more than twofold
between duplicated analyses were excluded. For hierarchical
clustering, we use Pearson’s correlation for similarity measure and
for average linkage clustering. GEO accession number: GSE23717.
Chimera formation
iPS cells were aggregated with zona-pellucida-free eight-cell-
stage embryos to generate chimeras. First, two-cell embryos were
flushed from ICR females at 1.5 dpc and cultured in microdrops of
mWitten medium until the eight-cell stage. The zona pellucida was
dissolved in Acid Tyrode’s solution (Sigma). After a short
treatment with trypsin (Nacalai Tesque), the iPS cells were
transferred into the microdrops of mWitten medium to make
contact with the denuded eight-cell embryos. Eight-cell embryos
aggregated with iPS cells were cultured overnight at 37uC, 5%
CO2. The aggregated morulae or blastocysts were transferred into
the oviducts of 0.5 dpc pseudopregnant females.
Supporting Information
Figure S1 Infection efficiency of retrovirus. DsRed
expression was observed in transduced source cells. Infection
efficiency was 81.5% of PaS cells, 85.3% of OP cells, and 80.7% of
TTF cells. Left: PaS cells. Middle: OP cells. Right: TTF cells.
Top: Phase contrast. Bottom: DsRed fluorescence. Bar, 250 mm.
(TIF)
Figure S2 Characterization of iPS cell lines. A, Expression
of the pluripotency-associated gene alkaline phosphatase in iPS
cells derived from TTF, OP, and PaS cells. Top: PaS-iPS clones.
Middle: OP-iPS clones. Bottom: TTF-iPS clones. Bar, 200 mm. B,
Histogram showed flow-cytometry analysis of the typical ES-cell
surface antigen SSEA-1. Top: PaS-iPS clones. Middle: OP-iPS
clones. Bottom: TTF-iPS clones. Blue line: experimental control.
Red line: sample stained SSEA-1.
(TIF)
Figure S3 Teratoma formation from iPS cells. iPS cells
were subcutaneously transplanted into nude mice. After 4–6
weeks, the teratomas were analyzed histologically with haematox-
ylin and eosin staining. 4F-OP-iPS #3 did not show differentiation
potential for three germ layers. 4F-TTF-iPS #1 did not
differentiate to mesoderm. Top: PaS-iPS clones. Middle: OP-iPS
clones. Bottom: TTF-iPS clones. Upper: Ectoderm. Center:
Mesoderm. Lower: Endoderm.
(TIF)
Figure S4 Eight-cell-stage aggregation. The iPS clones
were transferred into eight-cell-stage ICR embryos by aggregation
and cultured in vitro to blastocysts. Left: 3F-PaS-iPS #1. Middle:
3F-OP-iPS #4. Right: 3F-TTF-iPS #5. Top: Phase contrast.
Middle: EGFP expression. Bottom: Merged image.
(TIF)
Table S1 Induction efficiency of infected SeV infection.
PaS cells and TTF cells were infected with Sendai virus (SeV)
[27]. Multiplicity of infection (MOI) was changed to test optimum
density for generating iPS cells. Experiment 1 (Exp.01): Cells were
seeded on 12 well plates (0.99610
4 cells/well). Experiment 2
(Exp.02): PaS cells were seeded on 6 cm dishes (5.0610
4 cells/
well). TTF cells were seeded on 6 well plates (2.0610
4 cells/well).
Experiment 3 (Exp. 03): Cells were seeded on 12 well plates
(0.82610
4 cells/well). * cell aggregation. ** c-Myc was infected
with MOI=2.79 *** c-Myc was infected with MOI=4.65.
(TIF)
Table S2 Results summary of quality assessment. All
clones expressed alkaline phosphatase. SSEA-1 expression was
detected in over 1% of positive cells compared with control cells.
ES marker gene expression was detected by RT-PCR.
Transgene silencing was detected by RT-PCR. Teratoma
formation was detected by three times injection. Two clones
could not differentiate into three germ-layers. Count for
demethylation of Nanog promoter was over 80%. From
microarray analysis, although all clones were over 0.9 R
2 value,
we considered R
2 values over 0.92 compared with ES cells as
positive. Chimera mouse was detected by court colour. Germ-
line transmission was detected by court colour of offspring to
mating over 50% chimerism Chimera mice with Wild type mice.
ND: Not Done.
(TIF)
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